1) Investigación >
Artículos Publicados >

Por favor, use este identificador para citar o enlazar este ítem:

Título : A novel PDE1A coupled to M2AChR at plasma membranes from bovine tracheal smooth muscle
Autor : Mastromatteo-Alberga, Patrizzia
Placeres-Uray, Fabiola A
Alfonzo-González, Marcelo
Gonzalez de Alfonzo, Ramona
Lippo de Becemberg, Itala
Alfonzo R., Marcelo J.
Palabras clave : Airway smooth muscle
muscarinic antagonists
Fecha de publicación : 2-Nov-2015
Editorial : Journal of Receptors and Signal Transduction
Resumen : Muscarinic antagonists, via muscarinic receptors increase the cAMP/cGMP levels at bovine tracheal smooth muscle (BTSM) through the inhibition of phosphodiesterases (PDEs), displaying a similar behavior of vinpocetine (a specific-PDE1 inhibitor). The presence of PDE1 hydrolyzing both cyclic nucleotides in BTSM strips was revealed. Moreover, a vinpocetine and muscarinic antagonists inhibited PDE1 located at plasma membranes (PM) fractions from BTSM showing such inhibition, an M2AChR pharmacological profile. Therefore, a novel Ca2+/CaM dependent and vinpocetine inhibited PDE1 was purified and characterized at PM fractions from BTSM. This PDE1 activity was removed from PM fractions using a hypotonic buffer and purified some 38 fold using two columns (Q-Sepharose and CaM-agarose). This PDE1 was stimulated by CaM and inhibited by vinpocetine showing two bands in PAGE-SDS (56, 58 kDa) being the 58 kDa identified as PDE1A by Western blotts. This PDE1A activity was assayed with [3H]cGMP and [3H]cAMP exhibiting a higher affinity as Km (mM) for cGMP than cAMP but being close values with Vmax cAMP/cGMP ratio of 1.5. The co-factor Mg2+ showed similar K(A) (mM) for both cyclic nucleotides. Vinpocetine showed similar inhibition concentration 50% (IC50 of 4.9 and 4.6 mM) for cAMP and cGMP, respectively. CaM stimulated the cyclic nucleotides hydrolysis by PDE1A exhibiting similar activation constant as K(CaM), in nM range. The original finding was the identification and purification of a vinpocetine and muscarinic antagonist-inhibited and CaMactivated PM-bound PDE1A, linked to M2AChR. A model of this novel signal transducing cascade for the regulation of cyclic nucleotides levels at BTSM is proposed. Abbreviations: ASM: Airway smooth muscle; BTSM: Bovine Tracheal Smooth Muscle; Benzamidine: amidinobenzene hydrochloride; CaM: calmodulin; CCh: carbamylcholine; cAMP: cyclic adenosine 30, 50-monophosphate; cGMP: cyclic guanosine 30,50- monophosphate; 4-DAMP: 4-diphenylacetoxy-N-methylpiperidine; DTT: 1:4-dithiothreitol; PDE1A: phosphodiesterase 1A; PDE1B: phosphodiesterase tipo 1B; PDE1C: phosphodiesterase tipo 1C; PMSF: phenylmethylsulphonylfluoride; IBMX: isobutyl-methylxanthine; GPCR: G protein-coupled receptors; mAchR or MAchR: muscarinic acetylcholine receptor; M2AChR: M2 muscarinic receptor; M3AChR: M3 muscarinic receptor; NO-sGC: NO sensitive soluble guanylyl cyclase; NPR-GC: Natriuretic Peptides Receptor guanylyl cyclase; TCA: Trichloroacetic acid; Vinpocetine: (3a: 16b)-eburnamenine-14-carboxylic ethyl ester acid
ISSN : 1079-9893
Aparece en las colecciones: Artículos Publicados

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
Copy of A novel PDE1A coupled to M2AChR at plasma membranes.pdf743.96 kBAdobe PDFVisualizar/Abrir

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2008 MIT and Hewlett-Packard - Comentarios